Home
Storia in 1 fonti
Why Is Werewolf Therapeutics Stock Gaining Friday? - Werewolf Therapeutics (NASDAQ:HOWL)
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.
Raccontata da
benzinga.com
Timeline cronologica
- ·
Werewolf Therapeutics Shares Surge 89.94% After Hours on EMD Serono Deal - Werewolf Therapeutics (NASDAQ:
Werewolf Therapeutics shares surge 89.94% after hours as $33 million deal with EMD Serono brings fresh non-dilutive cash.
- ·
Why Is Werewolf Therapeutics Stock Gaining Friday? - Werewolf Therapeutics (NASDAQ:HOWL)
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.